Loading
LS
Lobe Sciences Ltd. Stock: price and insider trades · Canada
Lobe Sciences Ltd.: what insiders have been doing
This page follows insider dealings at Lobe Sciences Ltd. as filed with SEDI. In the past year (18 October 2025 to 18 October 2026), 122 filings came from 13 insiders.
No insider sold shares on the market over the period. Instead, the filings list 36 purchases, made by 1 insider. The totals exclude 36 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 1 senior executive among the declarants.
For context, the typical company on the same exchange (median of 2,121 companies) published 11 filings over the same period, against 122 filings here. Our records for Lobe Sciences Ltd. go back to 2021, with 41 purchases and no sales on the open market in total.
The last purchase on record was published on 15 September 2026, which is 32 days ago.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
151
Thresholds
n/a
Buy Volume
€1,976
41 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleWesley Ramjeet19 buys
Financial data
· cache
CA$0.07
Last declaration on 30 September 2026
Declarations151 total
2,333,333 sharesRestricted Share UnitsTSXSEDI:4782865
1,166,667 sharesRestricted Share UnitsTSXSEDI:4782864
3,500,000 sharesRestricted Share UnitsTSXSEDI:4782861
Restricted Share UnitsTSXSEDI:4782860
500,000 sharesRestricted Share UnitsTSXSEDI:4777518
500,000 sharesCommon SharesTSXSEDI:4777517
3,510,331 sharesCommon SharesTSXSEDI:4777512
10,000 sharesCommon SharesTSXSEDI:4777511
Canonical exit: 11 Aug 2026 (T+90)
10,000 sharesCommon SharesTSXSEDI:4777510
Canonical exit: 11 Aug 2026 (T+90)
10,000 sharesCommon SharesTSXSEDI:4777509
Canonical exit: 10 Aug 2026 (T+90)
5,000 sharesCommon SharesTSXSEDI:4777508
Canonical exit: 26 May 2026 (T+90)
3,477,705 sharesCommon SharesTSXSEDI:4777506
15,000 sharesCommon SharesTSXSEDI:4777504
Canonical exit: 4 Sept 2025 (T+90)
5,000 sharesCommon SharesTSXSEDI:4777501
Canonical exit: 28 Aug 2025 (T+90)
10,000 sharesCommon SharesTSXSEDI:4777499
Canonical exit: 12 Aug 2025 (T+90)
13,500 sharesCommon SharesTSXSEDI:4777497
Canonical exit: 7 Aug 2025 (T+90)
50,000 sharesCommon SharesTSXSEDI:4777495
Canonical exit: 6 Aug 2025 (T+90)
10,000 sharesCommon SharesTSXSEDI:4777482
Canonical exit: 4 Aug 2025 (T+90)
104,000 sharesCommon SharesTSXSEDI:4777481
Canonical exit: 3 Aug 2025 (T+90)
20,000 sharesCommon SharesTSXSEDI:4777480
2,333,333 sharesCommon SharesTSXSEDI:4777479
50,000 sharesCommon SharesTSXSEDI:4777478
Canonical exit: 17 Apr 2025 (T+90)
155,000 sharesCommon SharesTSXSEDI:4777477
Canonical exit: 8 Apr 2025 (T+90)
10,000 sharesCommon SharesTSXSEDI:4777476
Canonical exit: 19 Mar 2025 (T+90)
25,000 sharesCommon SharesTSXSEDI:4777472
Canonical exit: 14 Nov 2024 (T+90)
25 of 151 declarations
About Lobe Sciences Ltd.
Lobe Sciences Ltd. is a Toronto Stock Exchange-listed company focused on developing cannabinoid-based treatments. It aims to enhance mental health and well-being through research and innovation.
